Abc Biopply Ag
@biopply.com
abc biopply humanized disease models predict patients reaction to treatment - Our proprietary technology creates hundreds of miniature versions of patient organs in a laboratory setting, using both healthy and diseased tissues. Our innovative models bridges the predictive gap between the lab and the clinic. NAM, NAM technology; preclinical non animal models;
Abc Biopply Ag's Company Logos
Abc Biopply Ag's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#DA7169
Japonica
218, 113, 105
4, 60, 63
0, 48, 52, 15
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#10397B
Chathams Blue
16, 57, 123
217, 77, 27
87, 54, 0, 52
About Abc Biopply Ag
Our unique and exceptional services revolve around our proprietary 3D cell culture platform, 3D CoSeedis™. With this cutting-edge technology, we provide advanced solutions in preclinical disease models and drug discovery. At abc biopply, we offer a wide range of assay formats and downstream endpoints to support pharmaceutical and biotech companies in improving the predictiveness of their preclinical models and accelerating their drug discovery efforts.
Our dedicated 3D CoSeedis™ cell culture technology reduces the translational gap between in vitro and in vivo studies, allowing for a new level of differentiation and inter-cellular communication assays. Since our foundation in 2018, we have worked with numerous clients to develop customized assays and enhancements for specific projects, establishing ourselves as the leading Swiss expert in biostandardization. Key milestones in our journey include acquiring the 3D CoSeedis TM technology, validating our portfolio as a cell systems solution provider, and introducing 3D CoSeedis™ in chip assays.
Join abc biopply and experience the future of 3D cell culture technology. Contact us today for more information or subscribe to our TechTalk for the latest updates
Company type
Public Company
Year founded
2018
Company size
2-10 employees
